Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration

Indian Journal of Ophthalmology

Volumn 60, Issue 2, 2012, Pages 141-143

  Rush, Ryan ^a   Sheth, Saumil ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SYDNEY EYE HOSPITAL   (Australia)

Author keywords

Intravitreal triamcinolone acetonide; retinochoroiditis; toxoplasmosis

Indexed keywords

ANTIINFLAMMATORY AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CHOROIDITIS; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; OPPORTUNISTIC INFECTION; PARASITOLOGY; RETINITIS; TOXOPLASMOSIS; UVEITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; CHOROIDITIS; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; OPPORTUNISTIC INFECTIONS; PANUVEITIS; RETINITIS; TOXOPLASMOSIS; TRIAMCINOLONE ACETONIDE;

EID: 84859525822     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.94059     Document Type: Article

References (10)

1. Holland GN. Ocular toxoplasmosis: a global reassessment, Part I: epidemiology and course of disease. Am J Ophthalmol 2003; 136: 973-88. (Pubitemid 37485762)
2. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973; 57: 1-17.
3. Sabates R, Pruett RC, Brockhurst RJ. Fulminant ocular toxoplasmosis. Am J Ophthalmol 1981; 92: 497-503. (Pubitemid 11030205)
4. Engstrom RE Jr, Hollang GN, Nussenblatt RB, Jabs DA. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 1991; 111: 601-10.
5. O'Connor GR, Frenkel JK. Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy. Arch Ophthalmol 1976; 94: 213.
6. Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 2001; 32: 183-92.
7. Aggio FB, Muccioli C, Belfort R Jr. Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye (Lond) 2006; 20: 1080-2. (Pubitemid 44340334)
8. Nóbrega MJ, Rosa EL. Toxoplasmosis retinochoroiditis after photodynamic therapy and intravitreal triamcinolone for a supposed choroidal neovascularization: A case report. Arq Bras Oftalmol 2007; 70: 157-60.
9. Backhouse O, Bhan KJ, Bishop F. Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye (Lond) 2008; 22: 1200-1.
10. Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 1999; 106: 1554-63. (Pubitemid 30214356)